.gif){kind=logo}
Analyst upgrades:- Merriman upgraded shares of Akamai (NASDAQ:AKAM) to Buy from Neutral as they believe consensus expectations are now realistic and already reflect macro headwinds. Merriman also thinks the company's cost reductions could generate upside to EPS estimates.
- JP Morgan upgraded Novo Nordisk (NYSE:NVO) to Overweight from Neutral on expectations the company's diabetes drug will gain U.S. approval.
- Credit Suisse upgraded Pfizer (NYSE:PFE) to Outperform from Neutral and raised their target to $20 from $19 citing the merits of the Wyeth (WYE) deal and valuation.
- Quality Systems (NASDAQ:QSII) was upgraded to Buy from Neutral at Piper Jaffray.
- Parexel (NASDAQ:PRXL) was raised to Outperform from Market Perform at Wachovia.
- Ferro (NYSE:FOE) was upgraded at KeyBanc to Hold from Underweight.
Analyst downgrades:
- Keefe Bruyette downgraded NYSE Euronext (NYSE:NYX) to Market Perform from Outperform as they believe unfavorable pricing trends and lower than expected volume in Europe will limit the company's earnings growth. The firm has a $25 target on the stock.
- Jefferies downgraded PetroQuest Energy (NYSE:PQ) to Hold from Buy as they believe the company's capex cuts could limit its reserve growth this year. The firm lowered their target price to $6 from $12.
- Goldman downgraded International Paper (NYSE:IP) to Sell from Neutral based on expectations for a 2009 earnings loss and a potential dividend cut.
- Itron (NASDAQ:ITRI) was cut to Neutral from Buy at UBS.
- E-Trade was lowered at Barclays to Equal Weight from Overweight.
- Charles Schwab (NASDAQ:SCHW) was downgraded to Market Perform from Outperform at Bernstein.
- Auriga initiated SanDisk (NASDAQ:SNDK) with a Sell rating and $8 target and believes the company's cash burn and uncertain demand will drive shares lower.
- Merriman started Imagi International (OTCQX:IIHNY) with a Buy rating. The firm believes the company is well-positioned to capitalize on the growing consumer demand for CG-animated pictures.
- Thermo Fisher (NYSE:TMO) was initiated with an Outperform rating at Cowen, citing compelling valuation and product mix.
The week in preview: No turkey earnings from Tyson, Hormel, Cracker Barrel ...
Comfort Zone Investing: Intel is saying something ... can you hear it?
Twitter finally reveals revenue ambition, wants to be Google -- but not yet
